{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:57:22Z","timestamp":1789516642343,"version":"build-2803163510"},"reference-count":112,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2014.00052","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T14:51:19Z","timestamp":1418395879000},"source":"Crossref","is-referenced-by-count":17,"title":["Atypical Hemolytic Uremic Syndrome Post-Kidney Transplantation: Two Case Reports and Review of the Literature"],"prefix":"10.3389","volume":"1","author":[{"given":"Sami","family":"Alasfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Alachkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5527\/wjn.v2.i3.56","article-title":"Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations","volume":"2","author":"Salvadori","year":"2013","journal-title":"World J Nephrol"},{"issue":"8326 Pt 1","key":"B3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(83)91987-6","article-title":"Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin","volume":"1","author":"O\u00e2\u20ac\u2122Brien","year":"1983","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.trre.2013.07.003","article-title":"Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation","volume":"27","author":"Zuber","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0140-6736(73)92645-7","article-title":"Letter: plasma-C3 in haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura","volume":"2","author":"Cameron","year":"1973","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrneph.2010.155","article-title":"New insights into postrenal transplant hemolytic uremic syndrome","volume":"7","author":"Zuber","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","article-title":"Complement factor H related proteins (CFHRs)","volume":"56","author":"Skerka","year":"2013","journal-title":"Mol Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/MOP.0b013e32835df48a","article-title":"Complement disorders and hemolytic uremic syndrome","volume":"25","author":"Joseph","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fr\u00c3\u00a9meaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/hmg\/ddi099","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum Mol Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.molimm.2005.11.008","article-title":"Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree","volume":"43","author":"Esparza-Gordillo","year":"2006","journal-title":"Mol Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/jmg.2005.030783","article-title":"The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts","volume":"42","author":"Fremeaux-Bacchi","year":"2005","journal-title":"J Med Genet"},{"issue":"5","key":"B16","doi-asserted-by":"publisher","first-page":"e00146","DOI":"10.1042\/BSR20140117","article-title":"New functional and structural insights from updated mutational databases for complement factor H, factor I, membrane cofactor protein and C3","volume":"34","author":"Rodriguez","year":"2014","journal-title":"Biosci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","article-title":"The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20","volume":"12","author":"Caprioli","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1681\/ASN.2005010103","article-title":"Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome","volume":"16","author":"Kavanagh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molimm.2007.05.004","article-title":"Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome","volume":"45","author":"Kavanagh","year":"2008","journal-title":"Mol Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2215\/CJN.01260212","article-title":"Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome","volume":"8","author":"Hofer","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","volume":"18","author":"Sellier-Leclerc","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome","volume":"100","author":"Richards","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ki.2009.472","article-title":"Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome","volume":"77","author":"Bienaime","year":"2010","journal-title":"Kidney Int"},{"key":"B27","first-page":"9","article-title":"Atypical hemolytic-uremic syndrome","volume-title":"GeneReviews\u00c2\u00ae [Internet]","author":"Noris","year":"2013"},{"key":"B28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/eji.200939280","article-title":"Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I","volume":"40","author":"Nilsson","year":"2010","journal-title":"Eur J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"E177","DOI":"10.1111\/petr.12151","article-title":"Post-transplant recurrence of atypical hemolytic uremic syndrome in a patient with thrombomodulin mutation","volume":"17","author":"Sinibaldi","year":"2013","journal-title":"Pediatr Transplant"},{"key":"B30","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00467-009-1415-3","article-title":"A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome","volume":"25","author":"Tawadrous","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00467-008-0872-4","article-title":"Complement and the atypical hemolytic uremic syndrome in children","volume":"23","author":"Loirat","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"E1445","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome","volume":"31","author":"Maga","year":"2010","journal-title":"Hum Mutat"},{"key":"B34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1681\/ASN.2007080923","article-title":"The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome","volume":"19","author":"Martinez-Barricarte","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1182\/blood-2009-05-223834","article-title":"Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome","volume":"114","author":"Abarrategui-Garrido","year":"2009","journal-title":"Blood"},{"issue":"Suppl 8","key":"B36","doi-asserted-by":"publisher","first-page":"I9","DOI":"10.1016\/j.vaccine.2008.11.021","article-title":"Complement factor H related proteins in immune diseases","volume":"26","author":"Skerka","year":"2008","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","article-title":"Atypical haemolytic uraemic syndrome associated with a hybrid complement gene","volume":"3","author":"Venables","year":"2006","journal-title":"PLoS Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2011-03-339903","article-title":"A novel hybrid CFH\/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome","volume":"119","author":"Francis","year":"2012","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"J\u00c3\u00b3zsi","year":"2008","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/jmg.2008.064766","article-title":"The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome","volume":"46","author":"Dragon-Durey","year":"2009","journal-title":"J Med Genet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00467-010-1446-9","article-title":"DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome","volume":"25","author":"Zipfel","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B42","first-page":"121","article-title":"A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome","volume":"70","author":"Westra","year":"2012","journal-title":"Neth J Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00467-003-1289-8","article-title":"The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children","volume":"18","author":"Loirat","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/BF00852876","article-title":"Post-transplantation outcome of patients with hemolytic-uremic syndrome: update","volume":"5","author":"H\u00c3\u00a9bert","year":"1991","journal-title":"Pediatr Nephrol"},{"key":"B45","first-page":"S51","article-title":"Recurrence of hemolytic uremic syndrome in renal transplant recipients","volume":"19","author":"Hebert","year":"1986","journal-title":"Kidney Int Suppl"},{"key":"B46","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/01.TP.0000085083.74065.1B","article-title":"Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections","volume":"76","author":"Artz","year":"2003","journal-title":"Transplantation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/00005792-200003000-00003","article-title":"Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Cooperatif de l\u00e2\u20ac\u2122Ile-de-France (GCIF)","volume":"79","author":"Lahlou","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/00007890-200108270-00033","article-title":"Recurrence of hemolytic uremic syndrome after renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study","volume":"72","author":"Quan","year":"2001","journal-title":"Transplantation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2215\/CJN.00050505","article-title":"Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background","volume":"1","author":"Bresin","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1399-3046.2008.00910.x","article-title":"Hemolytic uremic syndrome recurrence after renal transplantation","volume":"12","author":"Loirat","year":"2008","journal-title":"Pediatr Transplant"},{"key":"B51","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Am J Transplant"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1093\/ndt\/gfn063","article-title":"Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome","volume":"23","author":"Kwon","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1600-6143.2009.02586.x","article-title":"Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome","volume":"9","author":"Le Quintrec","year":"2009","journal-title":"Am J Transplant"},{"key":"B54","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1600-6143.2009.02870.x","article-title":"Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T","volume":"10","author":"Waters","year":"2010","journal-title":"Am J Transplant"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J Med Genet"},{"key":"B56","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1053\/j.ajkd.2008.06.027","article-title":"Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient","volume":"53","author":"Chan","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00467-006-0320-2","article-title":"A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome","volume":"22","author":"Geelen","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.molimm.2006.10.005","article-title":"A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation","volume":"44","author":"Nilsson","year":"2007","journal-title":"Mol Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00467-009-1188-8","article-title":"Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome","volume":"24","author":"Davin","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1681\/ASN.2005101051","article-title":"Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome","volume":"17","author":"Fremeaux-Bacchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"B62","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/TP.0000000000000200","article-title":"Atypical hemolytic uremic syndrome recurrence after kidney transplantation","volume":"98","author":"Matar","year":"2014","journal-title":"Transplantation"},{"key":"B63","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nm0602-582","article-title":"Local synthesis of complement component C3 regulates acute renal transplant rejection","volume":"8","author":"Pratt","year":"2002","journal-title":"Nat Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1111\/j.1600-6143.2006.01427.x","article-title":"Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene","volume":"6","author":"Zheng","year":"2006","journal-title":"Am J Transplant"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1182\/blood-2009-01-197640","article-title":"Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome","volume":"114","author":"Roumenina","year":"2009","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1097\/00007890-199805270-00023","article-title":"Recurrence of hemolytic-uremic syndrome in renal transplant recipients: a meta-analysis","volume":"65","author":"Ducloux","year":"1998","journal-title":"Transplantation"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1681\/ASN.2008111145","article-title":"Expression of complement components differs between kidney allografts from living and deceased donors","volume":"20","author":"Naesens","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/ajt.12130","article-title":"Complement mediated renal inflammation induced by donor brain death: role of renal C5a-C5aR interaction","volume":"13","author":"van Werkhoven","year":"2013","journal-title":"Am J Transplant"},{"key":"B70","doi-asserted-by":"publisher","first-page":"F1134","DOI":"10.1152\/ajprenal.00158.2010","article-title":"Acute ischemic injury to the renal microvasculature in human kidney transplantation","volume":"299","author":"Snoeijs","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1053\/j.ajkd.2004.09.012","article-title":"Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: successful treatment with intensive plasma exchanges and ganciclovir","volume":"45","author":"Olie","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B72","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00467-010-1708-6","article-title":"Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation","volume":"26","author":"Al-Akash","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00467-010-1603-1","article-title":"Pandemic influenza A (H1N1) 2009-associated hemolytic uremic syndrome","volume":"26","author":"Printza","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00467-010-1636-5","article-title":"Atypical hemolytic uremic syndrome associated with H1N1 influenza A virus infection","volume":"26","author":"Trachtman","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"B75","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1681\/ASN.V1161132","article-title":"Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation","volume":"11","author":"Murer","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1056\/NEJMoa010319","article-title":"BK-related polyomavirus vasculopathy in a renal-transplant recipient","volume":"345","author":"Petrogiannis-Haliotis","year":"2001","journal-title":"N Engl J Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00467-011-1879-9","article-title":"Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome","volume":"26","author":"Weitz","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.2215\/CJN.10181110","article-title":"Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome","volume":"6","author":"Nester","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1111\/j.1600-6143.2008.02399.x","article-title":"Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation","volume":"8","author":"Al-Massarani","year":"2008","journal-title":"Am J Transplant"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1111\/j.1600-6143.2006.01433.x","article-title":"mTOR inhibition induces endothelial progenitor cell death","volume":"6","author":"Miriuka","year":"2006","journal-title":"Am J Transplant"},{"key":"B81","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5414\/CNP67335","article-title":"De novo thrombotic microangiopathy. An underrated complication of renal transplantation","volume":"67","author":"Ponticelli","year":"2007","journal-title":"Clin Nephrol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","article-title":"Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation","volume":"8","author":"Le Quintrec","year":"2008","journal-title":"Am J Transplant"},{"key":"B83","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","article-title":"De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy","volume":"41","author":"Schwimmer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1097\/TP.0b013e318230c0bd","article-title":"Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab","volume":"92","author":"Wilson","year":"2011","journal-title":"Transplantation"},{"issue":"1","key":"B85","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1182\/asheducation-2004.1.407","article-title":"Recent advances in thrombotic thrombocytopenic purpura","volume":"2004","author":"Sadler","year":"2004","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B86","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/clc.20731","article-title":"Cardiovascular manifestations in patients with thrombotic thrombocytopenic purpura: a single-center experience","volume":"33","author":"Gandhi","year":"2010","journal-title":"Clin Cardiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00467-004-1565-2","article-title":"Atypical relapse of hemolytic uremic syndrome after transplantation","volume":"19","author":"Olie","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 1","key":"B88","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/nep.12195","article-title":"Atypical HUS associated with severe, unexpected antibody-mediated rejection post kidney transplant","volume":"19","author":"Stevenson","year":"2014","journal-title":"Nephrology (Carlton)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1111\/j.1600-6143.2012.04124.x","article-title":"Antibody mediated rejection associated with complement factor h-related protein 3\/1 deficiency successfully treated with eculizumab","volume":"12","author":"Noone","year":"2012","journal-title":"Am J Transplant"},{"key":"B90","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00467-008-0833-y","article-title":"Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation","volume":"23","author":"Davin","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"3 Pt 2","key":"B92","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/j.lpm.2011.11.013","article-title":"Management of hemolytic uremic syndrome","volume":"41","author":"Loirat","year":"2012","journal-title":"Presse Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/S0140-6736(02)08560-4","article-title":"Combined kidney and liver transplantation for familial haemolytic uraemic syndrome","volume":"359","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/j.1600-6143.2005.00783.x","article-title":"Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation","volume":"5","author":"Remuzzi","year":"2005","journal-title":"Am J Transplant"},{"key":"B95","first-page":"200","article-title":"Hyaluronan regulation of vascular integrity","volume":"1","author":"Lennon","year":"2011","journal-title":"Am J Cardiovasc Dis"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1161\/CIRCULATIONAHA.106.684852","article-title":"Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia","volume":"116","author":"Rehm","year":"2007","journal-title":"Circulation"},{"key":"B97","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00467-013-2722-2","article-title":"Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?","volume":"29","author":"Saland","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","article-title":"Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation","volume":"12","author":"Zuber","year":"2012","journal-title":"Am J Transplant"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1111\/j.1600-6143.2009.02817.x","article-title":"Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome","volume":"9","author":"Chatelet","year":"2009","journal-title":"Am J Transplant"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1111\/j.1600-6143.2011.03612.x","article-title":"Complement activation during liver transplantation-special emphasis on patients with atypical hemolytic uremic syndrome","volume":"11","author":"Koskinen","year":"2011","journal-title":"Am J Transplant"},{"key":"B101","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/TP.0b013e31827e31c9","article-title":"Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation","volume":"95","author":"de Vries","year":"2013","journal-title":"Transplantation"},{"key":"B102","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","article-title":"Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival","volume":"117","author":"Kelly","year":"2011","journal-title":"Blood"},{"key":"B103","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2010050451","article-title":"The development of atypical hemolytic uremic syndrome depends on complement C5","volume":"22","author":"de Jorge","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1056\/NEJMc0808527","article-title":"Eculizumab for atypical hemolytic-uremic syndrome","volume":"360","author":"Nurnberger","year":"2009","journal-title":"N Engl J Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/TP.0b013e3181ccd80d","article-title":"Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation","volume":"89","author":"Larrea","year":"2010","journal-title":"Transplantation"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1111\/j.1432-2277.2012.01497.x","article-title":"Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft","volume":"25","author":"Alachkar","year":"2012","journal-title":"Transpl Int"},{"key":"B107","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.trre.2013.04.002","article-title":"Eculizumab in renal transplantation","volume":"27","author":"Legendre","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1053\/j.ajkd.2009.08.011","article-title":"Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation","volume":"55","author":"Davin","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/ndt\/12.7.1425","article-title":"Recurrence of haemolytic-uraemic syndrome in renal transplants: a single-centre report","volume":"12","author":"Miller","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"B110","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1016\/j.transproceed.2012.07.141","article-title":"Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report","volume":"44","author":"Xie","year":"2012","journal-title":"Transplant Proc"},{"key":"B111","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/bmt.2009.242","article-title":"Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin","volume":"45","author":"Sakai","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B112","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrd3011","article-title":"Therapeutic potential of complement modulation","volume":"9","author":"Wagner","year":"2010","journal-title":"Nat Rev Drug Discov"}],"container-title":["Frontiers in Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T09:52:22Z","timestamp":1650793942000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2014.00052\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,12]]},"references-count":112,"URL":"https:\/\/doi.org\/10.3389\/fmed.2014.00052","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,12]]}}}